About the use in nuclear medicine of pharmaceuticals on the basis of the isotope ¹⁸F and its achievements on linear electron accelerators of NIK "Accelerator"
The importance widely used in the world of Radiopharmaceutical: 2-fluoro [¹⁸F]-2-deoxy-D-glucose (fluo-rideglucose, ¹⁸F) for the diagnosis of various diseases using PET and CT imaging are shown. Provides information about the levels of specific activity of aqueous solutions containing the isotope ¹⁸...
Gespeichert in:
| Datum: | 2017 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Національний науковий центр «Харківський фізико-технічний інститут» НАН України
2017
|
| Schriftenreihe: | Вопросы атомной науки и техники |
| Schlagworte: | |
| Online Zugang: | http://dspace.nbuv.gov.ua/handle/123456789/136189 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | About the use in nuclear medicine of pharmaceuticals on the basis of the isotope ¹⁸F and its achievements on linear electron accelerators of NIK "Accelerator" / A.I. Azarov, A.N. Dovbnya, M.A. Dolzhec, V.A. Kushnir, V.V. Mitrochenko, S.A. Perezhogin, L.I. Selivanov, V.A. Tereshchenko, V.Yu. Titov, D.V. Titov, V.A. Shevchenko, B.I. Shramenko // Вопросы атомной науки и техники. — 2017. — № 6. — С. 133-136. — Бібліогр.: 1 назв. — англ. |